Sheervalilou R, et al. Recent advances in iron oxide nanoparticles for brain cancer theranostics: from in vitro to clinical applications. Expert Opin Drug Deliv. 2021;18(7):949–77.

Article  PubMed  CAS  Google Scholar 

Johnson DR, et al. A radiologist’s guide to the 2021 WHO central nervous system tumor classification: part I—key concepts and the spectrum of diffuse gliomas. Radiology. 2022;304(3):494–508.

Article  PubMed  Google Scholar 

Park YW, Vollmuth P, Foltyn-Dumitru M, Sahm F, Choi KS, Park JE, Ahn SS, Chang JH, The KSH. WHO classification for gliomas and implications on imaging diagnosis: part 3—summary of imaging findings on glioneuronal and neuronal tumors. J Magn Res Imaging. 2021;58(6):1680–702.

Article  Google Scholar 

Sheervalilou R, et al. Circulating MiR-10b, MiR-1 and MiR-30a expression profiles in lung cancer: possible correlation with clinico-pathologic characteristics and lung cancer detection. Int J Mol Cell Med. 2019;8(2):118.

PubMed  PubMed Central  CAS  Google Scholar 

Sheervalilou R, et al. Using miR-10b, miR-1 and miR-30a expression profiles of bronchoalveolar lavage and sputum for early detection of non-small cell lung cancer. Biomed Pharmacother. 2017;88:1173–82.

Article  CAS  Google Scholar 

Shirvalilou S, et al. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: in vitro and in vivo evaluations. Chem Biol Interact. 2018;295:97–108.

Article  PubMed  CAS  Google Scholar 

Cerna T, et al. Nanocarrier drugs in the treatment of brain tumors. J Cancer Metastasis Treat. 2016;2:407–16.

Article  CAS  Google Scholar 

Forst DA, et al. Low-grade gliomas. Oncologist. 2014;19(4):403–13.

Article  PubMed  PubMed Central  Google Scholar 

Jakola AS, et al. Surgical resection versus watchful waiting in low-grade gliomas. Ann Oncol. 2017;28(8):1942–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Panciani PP, et al. Fluorescence and image guided resection in high grade glioma. Clin Neurol Neurosurg. 2012;114(1):37–41.

Article  PubMed  Google Scholar 

Darlix A, et al. Chemotherapy and diffuse low-grade gliomas: a survey within the European low-grade glioma network. Neuro-Oncol Practice. 2019;6(4):264–73.

Article  Google Scholar 

Caffo M, et al. Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas. Glioma. 2018;1(6):183.

Article  Google Scholar 

De Vries NA, et al. Blood–brain barrier and chemotherapeutic treatment of brain tumors. Expert Rev Neurother. 2006;6(8):1199–209.

Article  PubMed  Google Scholar 

Régina A, et al. Multidrug resistance in brain tumors: roles of the blood–brain barrier. Cancer Metastasis Rev. 2001;20:13–25.

Article  PubMed  Google Scholar 

Tavares MR, et al. Polymeric nanoparticles assembled with microfluidics for drug delivery across the blood-brain barrier. European Phys J Spec Topics. 2016;225(4):779–95.

Article  CAS  Google Scholar 

Batista CAS, Larson RG, Kotov NA. Nonadditivity of nanoparticle interactions. Science. 2015. https://doi.org/10.1126/science.1242477.

Article  PubMed  Google Scholar 

Shi J, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37.

Article  PubMed  CAS  Google Scholar 

Almanghadim HG, et al. Application of nanoparticles in cancer therapy with an emphasis on cell cycle. Cell Biol Int. 2021;45(10):1989–98.

Article  PubMed  CAS  Google Scholar 

Kafshdooz L, et al. Labour analgesia; molecular pathway and the role of nanocarriers: a systematic review. Artificial Cells, Nanomedicine, and Biotechnology. 2019;47(1):927–32.

Article  PubMed  CAS  Google Scholar 

Ghaznavi H, et al. Effects of folate-conjugated Fe2O3@ Au core–shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies. Med Oncol. 2022;39(9):122.

Article  PubMed  CAS  Google Scholar 

Mirzaghavami PS, et al. Folic acid-conjugated magnetic triblock copolymer nanoparticles for dual targeted delivery of 5-fluorouracil to colon cancer cells. Cancer Nanotechnology. 2022;13(1):12.

Article  CAS  Google Scholar 

Senapati S, et al. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3(1):1–19.

CAS  Google Scholar 

Shusta EV. Blood-brain barrier genomics, proteomics, and new transporter discovery. NeuroRx. 2005;2(1):151–61.

Article  PubMed  PubMed Central  Google Scholar 

Rip J, Schenk GJ, De Boer AG. Differential receptor-mediated drug targeting to the diseased brain. Expert Opin Drug Deliv. 2009;6(3):227–37.

Article  PubMed  CAS  Google Scholar 

Chen Y, Liu L. Modern methods for delivery of drugs across the blood–brain barrier. Adv Drug Deliv Rev. 2012;64(7):640–65.

Article  PubMed  CAS  Google Scholar 

Bhowmik A, Khan R, Ghosh MK. Blood brain barrier: a challenge for effectual therapy of brain tumors. BioMed Res Int. 2015;2015(1):20.

Google Scholar 

Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173–85.

Article  PubMed  CAS  Google Scholar 

Pardridge WM. Drug transport across the blood–brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959–72.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochimica et Biophysica Acta (BBA) Biomembranes. 2008;1778(3):660–9.

Article  PubMed  CAS  Google Scholar 

Daneman R, Prat A. The blood–brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412.

Article  PubMed  PubMed Central  Google Scholar 

Ballabh P, Braun A, Nedergaard M. The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16(1):1–13.

Article  PubMed  CAS  Google Scholar 

Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 2009;1(2):a002584.

Article  PubMed  PubMed Central  Google Scholar 

Wolburg H, Lippoldt A. Tight junctions of the blood–brain barrier: development, composition and regulation. Vascul Pharmacol. 2002;38(6):323–37.

Article  PubMed  CAS  Google Scholar 

Davies DC. Blood–brain barrier breakdown in septic encephalopathy and brain tumours. J Anat. 2002;200(6):639–46.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meewes C, et al. Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas. J Nucl Med. 2001;42(9):1338–45.

PubMed  CAS